MYRIAD GENETICS, INC. (MYGN) Net margin 2016–2025
MYRIAD GENETICS, INC. (MYGN) net profit margin by fiscal year — reported net income divided by reported revenue.
-44.4%FY2025 · since FY2016: 2.4% → -44.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -44.4% | -29.2 pp |
| FY2024 | -15.2% | +19.8 pp |
| FY2023 | -35.0% | -18.4 pp |
| FY2022 | -16.5% | -12.6 pp |
| FY2021 | -3.9% | +36.2 pp |
| FY2020 | -40.1% | -8.9 pp |
| FY2019 | -31.2% | -31.8 pp |
| FY2018 | 0.5% | -17.4 pp |
| FY2017 | 17.9% | +15.5 pp |
| FY2016 | 2.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More MYGN financial trends
MYGN RevenueMYGN Net incomeMYGN Gross profitMYGN Gross marginMYGN Operating incomeMYGN Operating marginMYGN Operating cash flowMYGN Free cash flowMYGN Capital expendituresMYGN Return on equityMYGN Stock buybacksMYGN Dividends paidMYGN Total assetsMYGN Total liabilitiesMYGN Shareholders’ equityMYGN overview →